最新ニュース PHX Minerals (NYSE:PHX) 株価情報

PHX Minerals

PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

CYAN

バタフライ・ネットワークおよびその他2つの5ドル未満の株ダウ平均株価指数は金曜日に50ドル以上上昇して取引を終えた。内部者が株を売買した場合、それは同社の見通しに対する彼らの信頼または懸念を示唆する。ペニー株に興味を持つ投資家やトレーダーは、この要素を総合的な投資や取引の意思決定の一因と考えることができよう。

ダウ平均株価指数は50ドルの上昇を記録　上昇の要因は？

PHX Minerals Inc

PHX ENERGY SERVICES CORP by PHX Energy Services Corp.

PHX Energy Services Corp

PHAXIAM Therapeutics SA SPONSORED ADR NEW

WIIM

PHX Minerals shares are trading higher after the company announced its board approved a strategic alternatives process.

PHX MINERALS INC., "PHX" or the "Company" (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>), today announced that its Board of Directors (the "Board") has agreed to initiate a process to evaluate certain strategic alternatives to maximize shareholder value, including a potential merger or sale of the Company. RBC Capital Markets, LLC has been retained as financial advisor to assist in the review process.

PHX Minerals Bags Board Approval For Strategic Alternatives Process Including Potential Merger Or Sale

Calls upon the PHX Board of Directors to engage with WhiteHawk to pursue and complete a transaction
Encourages PHX stockholders to reach out to PHX's Board and ask them to engage with WhiteHawk around a value-maximizing transaction
WhiteHawk Energy, LLC (together with its subsidiaries, "WhiteHawk"), calls for a response from the Board of Directors of PHX Minerals, Inc. ("PHX" or the "Company") related to WhiteHawk's proposal to acquire PHX in a $4.00 per share all-cash transaction.
"We are asking all stockholders to reach out to PHX to encourage discussions with WhiteHawk related to WhiteHawk's all cash proposal of $4.00 per share. We have previously demonstrated financing for this transaction to PHX and its advisors," says Daniel C. Herz, WhiteHawk's Chief Executive Officer. "WhiteHawk's proposal benefits all stockholders and represents a substantial premium to PHX's recent trading prices."

WhiteHawk Energy Calls For Response From Board Of PHX Minerals, Related To Its Proposal To Acquire PHX In A $4.00 Per Share All-Cash Transaction

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. The company reported quarterly sales of $9.137 million which missed the analyst consensus estimate of $9.274 million by 1.47 percent. This is a 0.48 percent decrease over sales of $9.181 million the same period last year.

Earnings

Earnings Misses

PHX Minerals Q4 2024 GAAP EPS $0.03 Misses $0.04 Estimate, Sales $9.137M Miss $9.274M Estimate

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) will release its quarterly earnings report on Wednesday, 2024-11-06. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate PHX Minerals to report an earnings per share (EPS) of $0.03.
Anticipation surrounds PHX Minerals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
The company's EPS beat by $0.03 in the last quarter, leading to a 3.69% increase in the share price on the following day.

<img src="https://www.benzinga.com/files/images/story/2024/1730837027_0.png" alt="eps graph" />
<h3>Tracking PHX Minerals's Stock Performance</h3>
Shares of PHX Minerals were trading at $3.44 as of November 04. Over the last 52-week period, shares are up 6.06%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PHX/earnings">To track all earnings releases for PHX Minerals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of PHX Minerals's Earnings

PHX Minerals shares are trading higher after the company announced WhiteHawk Energy sent a letter regarding its acquisition proposal.

The letter includes details of the extensive efforts WhiteHawk has made over the past 18 months to engage with PHX to maximize value for stockholders through a transaction.
Urges the PHX Board of Directors to engage with WhiteHawk to pursue and complete a transaction following unwillingness to engage over the past 18 months

WhiteHawk Energy Sends Letter To PHX Minerals Chairman Mark Behrman With Respect To Its $4.00 Per Share Proposal

Butterfly Network And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed higher by over 50 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Standard BioTools</h3>
<ul>
<li>The Trade: Standard BioTools Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NASDAQ">LAB</a>) Director Casdin Private Growth Equity Fund, L.P. <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,069,562 shares </a> at an average price of $1.61. To acquire these shares, it cost around $1.72 million.</li>
<li>What's Happening: On July 31, Standard BioTools reported worse-than-expected quarterly financial results and cut FY24 revenue guidance below estimates..</li>
<li>What Standard BioTools Does: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster.</li>
</ul>
<h3 class="wp-block-heading">Cyanotech</h3>
<ul>
<li>The Trade: Cyanotech Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#OTC">CYAN</a>) Director Michael A / Davis <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 10,000 shares at</a> an average price of $0.73. To acquire these shares, it cost around $7,250.</li>
<li>What's Happening: On Aug. 7, Cyanotech announced financial results for the first quarter of fiscal year 2025, ended June 30, 2024.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>
<h3 class="wp-block-heading">PHX Minerals</h3>
<ul>
<li>The Trade: PHX Minerals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) SVP – CFO Raphael D&#8217;Amico acquired a total of 3,000 shares at an average price of $3.30. The insider spent around $9,898 to buy those shares.</li>
<li>What's Happening: On Aug. 12, PHX Minerals reported better-than-expected third-quarter financial results.</li>
<li>What PHX Minerals Does: PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40306547/dow-settles-higher-but-records-weekly-loss-greed-index-remains-in-extreme-fear-zone">Dow Settles Higher But Records Weekly Loss: Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

Guidance

PHX Minerals Sees FY24 Total Production (Mmcfe) 9,700-10,300

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. The company reported quarterly sales of $9.541 million which beat the analyst consensus estimate of $8.123 million by 17.46 percent. This is a 26.77 percent increase over sales of $7.526 million the same period last year.

Earnings Beats

PHX Minerals Q3 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $9.541M Beat $8.123M Estimate

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.02 by 150 percent. This is a 103.7 percent decrease over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $7.869 million which missed the analyst consensus estimate of $8.059 million by 2.35 percent. This is a 50.74 percent decrease over sales of $15.973 million the same period last year.

PHX Minerals Q2 2024 GAAP EPS $(0.01) Misses $0.02 Estimate, Sales $7.869M Miss $8.059M Estimate

The Dow Jones index closed lower by over 30 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Power Solutions International </h3>
<ul>
<li>The Trade: Power Solutions International, Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/psix#OTC">PSIX</a>) 10% owner Neil Gagnon <a href="https://www.benzinga.com/quote/FTCI/analyst-ratings"> acquired a total of 1,321 shares </a> an average price of $2.00. To acquire these shares, it cost around $2,642.</li>
<li>What&rsquo;s Happening: On March 14, Power Solutions International announced fourth quarter and full year 2023 financial results.</li>
<li>What Power Solutions International Does: Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that primarily run on nondiesel fuels, including natural gas, propane, and gasoline.</li>
</ul>
<h3>VerifyMe</h3>
<ul>
<li>The Trade: VerifyMe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrme#NASDAQ">VRME</a>) Director Arthur B Laffer <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 11,095 shares at </a> at an average price of $1.37. To acquire these shares, it cost around $15,100.</li>
<li>What&rsquo;s Happening: On March 21, VerifyMe posted a profit for the fourth quarter.</li>
<li>What VerifyMe Does: VerifyMe Inc is a technology solutions company based in the United States. It markets a broad patent portfolio that includes patents in the field of authenticating products, people, and financial transactions.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/03/37927160/mccormick-td-synnex-and-3-stocks-to-watch-heading-into-tuesday"> McCormick, TD SYNNEX And 3 Stocks To Watch Heading Into Tuesday </a>
<h3>PHX Minerals </h3>
<ul>
<li>The Trade: PHX Minerals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phx#NYSE">PHX</a>) Director Mark T Behrman <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 23,000 shares </a> at an average price of $3.22. The insider spent around $74,047 to buy those shares. The company&rsquo;s Principal Accounting Officer Chad True also bought 1,000 shares.</li>
<li>What&rsquo;s Happening: On March 12, PHX Minerals posted upbeat quarterly sales.</li>
<li>What PHX Minerals Does: PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.</li>
</ul>
<h3>Retractable Technologies </h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/quote/RVP/analyst-ratings"> acquired a total of 3,612 shares </a> at an average price of $1.21. The insider spent around $4,368 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Pre-Market Outlook

PSIX

VRME

Retractable Technologies And 3 Other Stocks Under $4 Insiders Are Buying

Northland Capital Markets analyst Donovan Schafer maintains PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) with a Outperform and lowers the price target from $5 to $4.3.

Price Target

Analyst Ratings

Northland Capital Markets Maintains Outperform on PHX Minerals, Lowers Price Target to $4.3

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) reported its Q1 earnings results on Tuesday, March 12, 2024 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
PHX Minerals beat estimated earnings by 75.0%, reporting an EPS of $0.07 versus an estimate of $0.04.
Revenue was down $6.49 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 5.0% drop in the share price the next day.
Here's a look at PHX Minerals's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>0.04</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.05</td>
<td>0</td>
<td>0.27</td>
<td>0.09</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>10.48M</td>
<td>9.13M</td>
<td>10.63M</td>
<td>15.57M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>9.18M</td>
<td>7.53M</td>
<td>15.97M</td>
<td>18.27M</td>
</tr>
</tbody>
</table>

To track all earnings releases for PHX Minerals <a href="https://www.benzinga.com/quote/PHX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PHX Minerals: Q1 Earnings Insights

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. The company reported quarterly sales of $11.783 million which beat the analyst consensus estimate of $10.382 million by 13.50 percent. This is a 35.51 percent decrease over sales of $18.270 million the same period last year.

PHX Minerals Q1 2024 GAAP EPS $0.07, Inline, Sales $11.783M Beat $10.382M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) is likely to report earnings for its fourth quarter.
&bull; MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $530.30 million.
&bull; BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) is likely to report quarterly loss at $0.91 per share on revenue of $710 thousand.
&bull; Enfusion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $45.27 million.
&bull; Tupperware Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) is estimated to report earnings for its second quarter.
&bull; Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $214.08 million.
&bull; Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) is projected to report quarterly loss at $0.22 per share on revenue of $222.43 million.
&bull; FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $34.53 million.
&bull; Archer-Daniels Midland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) is projected to report quarterly earnings at $1.43 per share on revenue of $23.64 billion.
&bull; On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $510.19 million.
&bull; Chicago Atlantic Real (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFI#NASDAQ">REFI</a>) is projected to report quarterly earnings at $0.51 per share on revenue of $16.09 million.
&bull; Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $-250 thousand.
&bull; Kohl&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is estimated to report quarterly earnings at $1.28 per share on revenue of $5.70 billion.
&bull; PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWFL#NASDAQ">PWFL</a>) is likely to report quarterly loss at $0.10 per share on revenue of $34.34 million.
&bull; Lifetime Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCUT#NASDAQ">LCUT</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $197.93 million.
&bull; IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $476.18 million.
&bull; Bioventus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $123.96 million.
&bull; Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) is projected to report quarterly loss at $0.09 per share on revenue of $3.24 million.
&bull; Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) is expected to report quarterly loss at $0.10 per share on revenue of $201.84 million.
&bull; Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) is estimated to report earnings for its fourth quarter.
&bull; Hagerty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGTY#NYSE">HGTY</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $245.27 million.
&bull; ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) is projected to report earnings for its fourth quarter.
&bull; Core Molding Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMT#AMEX">CMT</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $70.75 million.
&bull; Intl Game Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) is projected to report quarterly earnings at $0.41 per share on revenue of $1.11 billion.
&bull; Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) is projected to report quarterly loss at $0.13 per share on revenue of $48.40 million.
<h3>Companies Reporting After The Bell</h3>
&bull; ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) is projected to report quarterly loss at $0.20 per share on revenue of $6.53 million.
&bull; Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $172.68 million.
&bull; MaxCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) is likely to report quarterly loss at $0.07 per share on revenue of $13.09 million.
&bull; Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $111.13 million.
&bull; Performant Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFMT#NASDAQ">PFMT</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $31.59 million.
&bull; Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $592.58 million.
&bull; Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) is likely to report quarterly loss at $0.08 per share on revenue of $27.00 million.
&bull; Rackspace Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) is projected to report quarterly loss at $0.04 per share on revenue of $714.72 million.
&bull; Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $45.74 million.
&bull; Intl General Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) is likely to report earnings for its fourth quarter.
&bull; Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is projected to report quarterly loss at $0.15 per share on revenue of $13.48 million.
&bull; Aligos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) is projected to report quarterly loss at $0.27 per share on revenue of $1.60 million.
&bull; Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $33.52 million.
&bull; Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) is likely to report earnings for its fourth quarter.
&bull; SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) is likely to report earnings for its fourth quarter.
&bull; Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) is projected to report quarterly loss at $2.00 per share on revenue of $2.10 million.
&bull; Doma Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOMA#NYSE">DOMA</a>) is likely to report quarterly loss at $1.30 per share on revenue of $69.42 million.
&bull; Beauty Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) is projected to report quarterly loss at $0.07 per share on revenue of $87.63 million.
&bull; Laird Superfood (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LSF#AMEX">LSF</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $8.74 million.
&bull; Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is projected to report quarterly loss at $0.13 per share on revenue of $29.34 million.
&bull; Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $4.43 million.
&bull; Heron Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) is expected to report quarterly loss at $0.16 per share on revenue of $30.97 million.
&bull; AdTheorent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTH#NASDAQ">ADTH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $56.20 million.
&bull; Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) is likely to report quarterly loss at $0.03 per share on revenue of $30.00 million.
&bull; Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $262.30 million.
&bull; icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.30 million.
&bull; Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) is expected to report quarterly loss at $0.18 per share on revenue of $145.56 million.
&bull; Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) is projected to report quarterly loss at $0.03 per share on revenue of $73.07 million.
&bull; Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) is likely to report quarterly loss at $1.38 per share on revenue of $1.06 million.
&bull; Transact Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TACT#NASDAQ">TACT</a>) is projected to report quarterly loss at $0.03 per share on revenue of $13.60 million.
&bull; loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $236.76 million.
&bull; CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) is estimated to report quarterly loss at $0.29 per share on revenue of $58.40 million.
&bull; Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) is likely to report quarterly loss at $0.10 per share on revenue of $42.84 million.
&bull; Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $480.25 million.
&bull; Westrock Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $226.02 million.
&bull; Eastern Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EML#NASDAQ">EML</a>) is likely to report earnings for its fourth quarter.
&bull; BRT Apartments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRT#NYSE">BRT</a>) is estimated to report earnings for its fourth quarter.
&bull; Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) is expected to report quarterly loss at $0.06 per share on revenue of $87.21 million.
&bull; Aware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWRE#NASDAQ">AWRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) is likely to report quarterly loss at $0.11 per share on revenue of $151.50 million.
&bull; Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) is projected to report quarterly loss at $0.23 per share on revenue of $69.06 million.
&bull; Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $47.25 million.
&bull; PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $9.37 million.
&bull; Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) is likely to report quarterly loss at $0.15 per share on revenue of $33.79 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADTH

ALGS

ATER

AWRE

BIRD

BLDE

BTAI

BTMD

CLOV

CLPT

CLSD

CRMD

CSBR

CYRX

DOMA

ENFN

GHLD

HGTY

HRTX

ICAD

IGIC

INVE

LCUT

MANU

MHLD

MNSO

MXCT

NATR

NOTE

NRGV

ONON

OPRT

PFMT

PHUN

PRPL

PRTH

PWFL

QFIN

QRHC

REFI

RERE

SIGA

SKIN

SNCR

SURG

SWIM

TACT

TNON

VERI

WEST

WKHS

Earnings Scheduled For March 12, 2024

PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here's what investors need to know before the announcement.
Analysts estimate that PHX Minerals will report an earnings per share (EPS) of $0.04. 
PHX Minerals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 4.55% drop in the share price the next day.
Here's a look at PHX Minerals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>0.04</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.05</td>
<td>0</td>
<td>0.27</td>
<td>0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1710172868_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of PHX Minerals were trading at $3.04 as of March 08. Over the last 52-week period, shares are up 14.77%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PHX/earnings">To track all earnings releases for PHX Minerals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of PHX Minerals's Earnings

Stifel analyst Derrick Whitfield maintains PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) with a Buy and lowers the price target from $5.7 to $5.5.

Stifel Maintains Buy on PHX Minerals, Lowers Price Target to $5.5

Revealing a significant insider sell on December 26, Edenbrook Capital LLC, 10% Owner at PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>), as per the latest SEC filing.
What Happened: After conducting a thorough analysis, LLC sold 1,575,000 shares of PHX Minerals. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000315131/000106299323023192//Archives/edgar/data/315131/000106299323023192/0001062993-23-023192-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total transaction value is $4,898,407.
The latest market snapshot at Wednesday morning reveals PHX Minerals shares down by 0.0%, trading at $3.35.
<h3>All You Need to Know About PHX Minerals</h3>
PHX Minerals, previously Panhandle Oil &amp; Gas, is an oil and natural gas mineral company that has employed a strategy to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The sale of natural gas, natural gas liquids, and oil continues to be the primary source of the company's revenue.
<h3>Financial Milestones: PHX Minerals's Journey</h3>
Decline in Revenue: Over the 3 months period, PHX Minerals faced challenges, resulting in a decline of approximately -47.67% in revenue growth as of 30 September, 2023. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 61.69%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): PHX Minerals's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 0.05.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.26.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 5.68, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 2.16 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 4.67 reflects market recognition of PHX Minerals's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000315131">Check Out The Full List Of PHX Minerals's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Decision: Edenbrook Capital LLC Offloads $4.90M Worth Of PHX Minerals Stock

Stifel analyst Derrick Whitfield maintains PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) with a Buy and raises the price target from $5.4 to $5.7.

Stifel Maintains Buy on PHX Minerals, Raises Price Target to $5.7

Dividends

Commodities

Press Releases

PHX Minerals Declares Regular Dividend of $0.03 Per Share

PHX Minerals Inc. to Announce Quarterly Financial Results on Aug. 7 and Host Earnings Call on Aug. 8

PHX Minerals Reports Record Royalty Volumes for the Quarter Ended June 30, 2024; Increases Fixed Quarterly Dividend Payment 33%

LSB Industries, Inc. Announces the Retirement of Richard Roedel as Chairman of the Board of Directors

WhiteHawk Energy Reiterates Proposal to Acquire PHX Minerals, Inc. for $4.00 per Share in an All-Cash Transaction

PHX Minerals Inc. to Announce Quarterly Financial Results on Nov. 6 and Host Earnings Call on Nov. 7

PHX Minerals Reports Results for the Quarter Ended Sept. 30, 2024

WhiteHawk Energy Calls for Response from Board of PHX Minerals, Inc. related to its Proposal to Acquire PHX in a $4.00 per Share All-Cash Transaction

PHX Minerals Inc. Response to the WhiteHawk Proposal

PHX Minerals Inc. Announces Strategic Alternatives Process

Amplify Energy

Battalion Oil

Berry Corp

Cross Timbers Royalty

Empire Petroleum Corporation Common Stock

Empire Petroleum

Evolution Petroleum Corporation, Inc. Common Stock

Evolution Petroleum

Gran Tierra Energy

Houston American Energy Corporation Common Stock

Houston American Energy

Indonesia Energy Corporation Limited Ordinary Shares

Indonesia Energy Corp

MV Oil Trust Units of Beneficial Interests

MV Oil

Mexco Energy

New Era Helium

North European Oil Royality Trust Common Stock

North European Oil

PEDEVCO

PrimeEnergy Resources Corporation - Common Stock

PrimeEnergy Resources

Prairie Operating

PermRock Royalty Trust

Permianville Royalty

Ring Energy

SandRidge Energy

San Juan Basin Royalty Trust Common Stock

San Juan Basin Royalty

Tamboran Resources Corporation Common stock

Tamboran Resources

US Energy

VOC Energy Trust Units of Beneficial Interest

VOC Energy

W&T Offshore

Northland Capital Markets

Stifel

Johnson Rice

Alliance Global Partners

Panhandle Royalty

バタフライ・ネットワークおよびその他2つの5ドル未満の株
ダウ平均株価指数は金曜日に50ドル以上上昇して取引を終えた。内部者が株を売買した場合、それは同社の見通しに対する彼らの信頼または懸念を示唆する。ペニー株に興味を持つ投資家やトレーダーは、この要素を総合的な投資や取引の意思決定の一因と考えることができよう。
以下に5ドル未満の注目すべきペニー株の最近のインサイダー取引について見てみよう。詳細は<a href="https://www.benzinga.com/sec/insider-trades/">Benzingaのインサイダー取引</a>を参照。
<h3 class="wp-block-heading">Standard BioTools</h3>
<ul>
<li>取引: Standard BioTools Inc(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NASDAQ">LAB</a>)のCasdin Private Growth Equity Fund、L.P.氏が1.61ドルの平均価格で1,069,562株を<a href="https://www.benzinga.com/sec/insider-trades/">合計1,72百万ドルで購入した</a>。</li>
<li>出来事: 7月31日、Standard BioToolsは決算を発表、予想を下回る結果を報告し、2024年度の売上高見通しも引き下げた。</li>
<li>Standard BioToolsの事業:Standard BioToolsは、バイオメディカル研究者が医薬品をより早く開発するためを支援する技術を開発、製造、販売している。</li>
</ul>
<h3 class="wp-block-heading">Cyanotech</h3>
<ul>
<li>取引: Cyanotech Corporation（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CYAN#OTC">CYAN</a>）のMichael A / Davis氏は、0.73ドルの平均価格で1万株を<a href="https://www.benzinga.com/sec/insider-trades/">合計7,250ドルで購入した</a>。</li>
<li>出来事:8月7日、Cyanotechは2024年6月30日に終了した2025会計年度第1四半期の決算を発表した。</li>
<li>Cyanotechの事業: Cyanotech Corpは、栄養補助食品市場向けのミドロモの自然製品を生産している。</li>
</ul>
<h3 class="wp-block-heading">PHX Minerals</h3>
<ul>
<li>取引: PHX Minerals Inc。(NYSE：<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) SVP – CFOのRaphael D&#8217;Amico氏は3.30ドルの平均価格で1万株を<a href="https://www.benzinga.com/sec/insider-trades/">合計9,898ドルで購入した</a>。</li>
<li>出来事: 8月12日、PHX Mineralsは第3四半期の決算で予想を上回る結果を報告した。</li>
<li>PHX Mineralsの事業: PHX Minerals Incは、掘削から永久ミネラルおよび天然ガスへの所有権への事業の核心を移行させることを目指している石油・天然ガス鉱物会社。</li>
</ul>
次に読むべきは
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40306547/dow-settles-higher-but-records-weekly-loss-greed-index-remains-in-extreme-fear-zone">ダウは高く推移も週間損失を記録、『極度の恐怖』ゾーンに留まるGreed Index</a></li>
</ul>

Comments

PHX Minerals

ニュース

最新ニュース PHX Minerals (NYSE:PHX) 株価情報

月曜日, 8 12, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル